Navigation Links
CleveMed Receives $1.23 Million in NIH Funding to Develop a System to Augment Deep Brain Stimulation Programming in Parkinson's Disease
Date:10/7/2008

CLEVELAND, Oct. 7 /PRNewswire/ -- Cleveland Medical Devices Inc. (CleveMed) announced it has been awarded $1.23 million in NIH SBIR FastTrack funding from the National Institute on Aging to develop ParkinTune(TM), a system to augment stimulator programming in deep brain stimulation (DBS) procedures for Parkinson's disease (PD). CleveMed is collaborating with clinicians at the Center for Neurological Restoration of the Cleveland Clinic Foundation, a world renowned, pioneering DBS surgery center.

"Clinical tools are needed to improve deep brain stimulation procedures and patient outcomes," said Dr. Jerrold Vitek, Director of the Cleveland Clinic Foundation Neuromodulation Research Center and grant collaborator. "Assisting neurologists by objectively capturing and tracking motor performance in response to stimulation settings with a compact wireless device should show efficacy in optimizing patient outcomes in Parkinson's disease."

DBS is a surgical procedure for treating PD motor symptoms, such as tremor, bradykinesia (slowed movements) and rigidity, when medication is no longer effective. During surgery, an electrode is implanted in a targeted location in the brain. Once inserted, the stimulator intensity, frequency and duration are programmed. This programming is also necessary in several outpatient sessions over a period of months post surgery. Each time the stimulator settings are changed the patient's motor symptoms are evaluated using the Unified Parkinson's Disease Rating Scale (UPDRS) motor exam, a subjective evaluation clinicians use to assess PD motor symptoms. The process is repeated multiple times until optimal stimulator parameters are found which minimize motor symptoms. Utilizing an automated technology platform to objectively quantify Parkinson's motor symptoms and suggest optimized stimulation settings based on those measurements may reduce the time and cost of programming sessions as well as improve patient outcomes.

"CleveMed has previously demonstrated efficacy in objectively monitoring movement disorder motor symptoms," said Dr. Joseph Giuffrida, Director of CleveMed's Division of Movement Disorders and grant principle investigator. "Expanding this technology and knowledge to DBS programming should provide neurologists with an innovative tool for understanding specific neural mechanisms of DBS on motor control."

The objective is to further commercialize Kinesia(TM), a clinical device currently on the market for monitoring upper extremity PD symptoms, for a new area of use which will aid clinicians with stimulator programming during DBS surgery and post surgical tuning sessions to ensure optimal control of motor symptoms has been achieved. The technology to be developed will further strengthen our product portfolio and leading position in the area of ambulatory monitoring for movement disorders. The system will utilize a wireless patient unit worn on the hand that will transmit the kinematic motion data to a nearby laptop. The laptop will display objective symptom information and suggested stimulation settings to help the clinician rapidly program stimulation parameters. By providing repeatable and objective biokinetic data of patient symptoms along with visual examination, ParkinTune may reduce time and costs associated with DBS surgeries and outpatient programming sessions as well as increase patient comfort and overall outcomes.

About CleveMed - CleveMed was founded with the goal of developing innovative telemetry devices for a variety of medical applications. Today, CleveMed is developing and pioneering the use of novel wireless monitoring systems for high growth neurology and rehabilitation applications, including brain monitoring, sleep disorders and movement disorders. Through these innovations, CleveMed has developed a growing range of products that address the needs of the medical, research and academic communities.


'/>"/>
SOURCE CleveMed
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. DxTech Receives Development Funding
2. Texas Health Resources Receives Grant From Robert Wood Johnson Foundation to Support Prevention of Family Violence
3. MedPlexus Electronic Health Record Receives 08 CCHIT Certification
4. Herley New England Receives Additional $1.3 Million Contract Award from Lockheed Martin for the Multi-Mission Helicopter
5. Updated MD-CARE Act Receives Final Congressional Approval
6. Diabetes Research and Awareness Receives Big Boost Thanks to Generous Gift from Thomas McInerney
7. Digirad Corporation Receives FDA 510(k) Clearance for nSPEED(R) Reconstruction Software for Improved Image Quality in Less Time With Less Radiation
8. Partnership for Peak Healthcare Performance Receives Grant from Aetna Foundation to Improve Area Diabetes Care
9. Freedom Meditech Receives JumpStart Investment
10. Lumension Security Receives Frost & Sullivan 2008 Global Market Penetration Leadership Award
11. WorldHeart Receives Favorable Decision to Continue NASDAQ Listing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Comfort Keepers® of ... Cancer Society and the Road To Recovery® program to drive cancer patients to and ... other adults to ensure the highest quality of life and ongoing independence. Getting ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative ... has initiated cultivation and processing operations at its production facility, and opened its ... Puradigm is the manufacturer of a complete system of proactive air and surface ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... 2016 Story Highlights: ... within the health care industry is causing providers to ... , Deloitte offers a suite of solutions for health ... efficient cost optimization: labor resource analysis, revenue cycle optimization ... better outcomes and better economics ...
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, Inc., ... development and manufacturing of collagen and mineral based ... today that Bill Messer has joined ... to further leverage the growing portfolio of oral ... Bill joins the Collagen Matrix executive ...
Breaking Medicine Technology: